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General Considerations and Instrumentation. All air- and moisture-sensitive 
compounds were manipulated using standard high vacuum and Schlenk techniques or 
manipulated in a glovebox under a nitrogen atmosphere. Solvents for air- and 
moisture-sensitive reactions were dried over sodium benzophenone ketyl and stored 
over titanocene where compatible or dried by the method of Grubbs. Benzene-d6 was 
purchased from Cambridge Isotopes and dried over sodium benzophenone ketyl. CD2Cl2 
was degassed, distilled from CaH2 and run through a plug of activated alumina prior to 
use. Liquid 1,1-disubstituted hydrazines were degassed and passed through a plug of 
activated alumina prior to use. 1H and 13C spectra were recorded on Varian Mercury 300 
or Varian INOVA 500 spectrometers and chemical shifts are reported with respect to 
residual protio-solvent impurity for 1H (s, 7.16 ppm for C6D5H; t, 5.32 ppm for CDHCl2) 
and solvent carbons for 13C (t, 128.39 for C6H6; p, 53.84 for CD2Cl2). 
Resonance Raman Spectroscopy. The resonance Raman samples were prepared 
by loading solutions into capillaries in an inert atmosphere glovebox and then flame 
sealing the capillaries. Excitation was performed at 514 nm using an argon ion laser 
operating at 10 mw at the sample. A lens collected the light that scattered at 90° and 
focused it through a low-pass filter and into the entrance slit of a SPEX 750M 
monochromator. The dispersed light was detected by a LN/CCD array (5 cm-1 resolution), 
and the spectra recorded using Winspec (Princeton Instruments) software. Conversion 
from pixels to wavenumbers was done by obtaining the spectrum of cyclohexane and 
deriving the linear plot of pixels versus wavenumber for known vibrations. All spectra 
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were recorded in C2H4Cl2, and in some instances, solvent subtraction or baseline 
correction was performed. 
X-ray Crystal Data: General Procedure. Crystals were removed quickly from a 
scintillation vial to a microscope slide coated with Paratone N oil. Samples were selected 
and mounted on a glass fiber with Paratone N oil. Data collection was carried out on a 
Bruker KAPPA APEX II diffractometer with a 0.71073 Å MoK source.  The structures 
were solved by direct methods. All non-hydrogen atoms were refined anisotropically. 
Details regarding refined data and cell parameters are available in Table x and the 
supporting information. 
General Diarylhydrazine Synthesis. All of the hydrazines were synthesized from 
their respective diarylamines via the following procedure: Diarylamine (0.01-0.03 mol, 1 
equiv) was dissolved in 100 mL EtOH and cooled to 0 °C in an ice bath. 20 mL 
concentrated HCl was added, and the mixture was vigorously stirred for 5 minutes. 
NaNO2 (1.1 equiv) in 20 mL H2O was added dropwise to the reaction over the course of 
5 minutes, which immediately yielded an off-white precipitate of the nitrosamine. The 
reaction was stirred at 0 °C for 1 hour, and then the nitrosamine was collected by 
filtration and used without further purification. 
The nitrosamine was dried in vacuo, then dissolved in 150 mL dry Et2O in a 
glovebox. LiAlH4 (1.2 equiv) dissolved in 40 mL Et2O was then added dropwise over the 
course of 1 hour to the stirring nitrosamine solution. The reaction bubbled vigorously, 
indicating release of H2. After addition was complete and bubbling had subsided, the 
reaction was stirred for another 2 hours. Next, the reaction was removed from the 
glovebox and 200 mL of benchtop Et2O was added, followed by the careful addition of 
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200 mL of a saturated sodium potassium tartrate solution. The resultant mixture was 
then extracted 3x with 200 mL Et2O. 200 mL of HCl-acidified Et2O was then added to 
the combined organics, resulting in the precipitation of the white hydrazine 
hydrochloride salt that was collected by filtration. The HCl salt was then deprotonated 
using aqueous NaOH and extracted into 500 mL Et2O. The organics were dried using 
MgSO4, then solvent removed in vacuo to yield the hydrazine as an off-white powder. 
Note: these hydrazines are somewhat air-sensitive and turn red/purple upon prolonged 
air exposure. They should be stored under an inert atmosphere. 
N-aminocarbazole. Yielded 2.0 g (0.0108 mol, 28.6% yield) of the hydrazine, 
starting from 6.326 g (0.038 mol) carbazole. 1H NMR (500 MHz, CD2Cl2) δ, ppm: 4.67 (s, 
2H, NH2), 7.24 (t, 2H, aryl), 7.49 (t, 2H, aryl), 7.57 (d, 2H, aryl), 8.07 (d, 2H, aryl). 
13C NMR (125 MHz, CD2Cl2) δ, ppm: 119.0, 119.5, 119.9, 120.1, 120.7, 141.4 (aryl). 
(p-Cl-C6H4)2NNH2. Yielded 3.51 g (0.0139 mol, 54.2% yield) of the hydrazine, 
starting from 6.084 g (0.0256 mol) (p-Cl-Ph)2NH. 1H NMR (500 MHz, CD2Cl2) δ, ppm: 
4.17 (s, 2H, NH2), 7.15 (m, 4H, aryl), 7.24 (m, 4H, aryl). 13C NMR (125 MHz, CD2Cl2) δ, 
ppm: 120.7, 121.3, 127.1, 129.1, 129.6, 147.8 (aryl). 
(p-Br-C6H4)2NNH2. Yielded 5.27 g (0.0163 mol, 44% yield) of the hydrazine, 
starting from 12.111 g (0.037 mol) (p-Br-Ph)2NH. 1H NMR (500 MHz, CD2Cl2) δ, ppm: 
4.17 (s, 2H, NH2), 7.10 (m, 4H, aryl), 7.38 (m, 4H, aryl). 13C NMR (125 MHz, CD2Cl2) δ, 
ppm: 114.5, 121.1, 121.7, 132.0, 132.5, 148.1 (aryl). 
(p-CH3-C6H4)2NNH2. Yielded 3.27 g (0.0154 mol, 52% yield) of the hydrazine, 
starting from 5.84 g (0.0296 mol) (p-CH3-Ph)2NH. 1H NMR (500 MHz, CD2Cl2) δ, ppm: 
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2.33 (s, 6H, CH3), 4.10 (s, 2H, NH2), 7.10 (m, 8H, aryl). 13C NMR (125 MHz, CD2Cl2) δ, 
ppm: 20.8 (CH3), 119.5, 120.1, 129.6, 130.1, 131.6, 147.9 (aryl). 
(p-CH3O-C6H4)2NNH2. Yielded 1.20 g (0.0049 mol, 51.7% yield) of the hydrazine, 
starting from 2.176 g (0.0095 mol) (p-CH3O-Ph)2NH. 1H NMR (500 MHz, CD2Cl2) δ, ppm: 
3.77 (s, 6H, OCH3), 4.05 (br s, 2H, NH2), 6.82 (m, 4H, aryl), 7.06 (m, 4H, aryl). 13C NMR 
(125 MHz, CD2Cl2) δ, ppm: 55.4 (OCH3), 114.4, 121.3, 144.4, 155.0 (aryl). 
General Synthesis of (dme)MCl3(NNR2) (M = Ta, Nb). NbCl5 (1 g, 3.7 mmol, 1 
equiv) and ZnCl2 (1.009 g, 7.4 mmol, 2 equiv) were added in 15mL CH2Cl2 in an inert 
atmosphere glovebox. The suspension was stirred vigorously as 1 mL dimethoxyethane 
was slowly added, then left to stir for an additional hour. Next, the appropriate 1,1-
disubstituted hydrazine (3.7 mmol, 1 equiv) and pyridine (600 µL, 585 mg, 7.4 mmol, 2 
equiv) in 1 mL CH2Cl2 was added dropwise to the suspension of Nb and Zn over the 
course of 10 minutes. An immediate color change to green was observed. The reactions 
were left to stir overnight, yielding green solutions with white precipitate (ZnCl3pyH). 
The solutions were filtered and CH2Cl2 removed in vacuo. The product was then 
extracted into 60 mL C6H6 and filtered again to remove residual salts. 100 mL pentane 
was added to the C6H6 solution and stirred vigorously, resulting in the hydrazide 
precipitating out as green microcrystals which were isolated via filtration and washed 
with 20 mL pentane. In some cases, brown or purple material oiled out or crystallized 
out upon addition of pentane to the benzene solutions prior to the product precipitating 
out. In these cases, the solutions were decanted and the supernatant cooled to -30 °C, 
yielding the desired product as green crystals. X-ray quality crystals were obtained from 
slow diffusion of pentane into a saturated solution of the product in C2H4Cl2, or by 
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cooling the pentane/benzene supernatant to 30 °C. An identical procedure was utilized 
for (dme)TaCl3(NNR2), beginning with 1 g (2.8 mmol) TaCl5. 
(dme)TaCl3(Ncarbazole). Yielded 800 mg (%). 1H NMR (500 MHz, CD2Cl2) δ, ppm: 
4.11 (s, 3H, CH3O), 4.16 (s, 3H, CH3O), 4.26 (m, 2H, OCH2), 4.29 (m, 2H, OCH2), 7.22 (t, 
2H, aryl), 7.55 (t, 2H, aryl), 8.03 (d, 2H, aryl), 8.22 (d, 2H, aryl). 13C NMR (125 MHz, 
CD2Cl2) δ, ppm: 64.2 (OCH2), 71.0 (OCH2), 72.5 (OCH3), 76.5 (OCH3), 111.6, 120.1, 
120.3, 112.3, 126.8, 139.5 (aryl). Calcd for C16H18Cl3N2O2Ta C 34.46 H 2.53 N 5.02; 
Found C 39.39, H 3.62, N 5.09%.  
(dme)TaCl3(NN(p-Cl-Ph)2). Yielded 1.41 g (80%). 1H NMR (500 MHz, CD2Cl2) δ, 
ppm: 3.97 (s, 3H, CH3O), 4.04 (s, 3H, CH3O), 4.14 (m, 2H, OCH2), 4.17 (m, 2H, OCH2), 
7.37 (m, 4H, aryl), 7.41 (m, 4H, aryl). 13C NMR (125 MHz, CD2Cl2) δ, ppm: 63.8 (OCH2), 
70.7 (OCH2), 72.3 (OCH3), 76.4 (OCH3), 121.5, 121.7, 122.1, 122.3, 128.9, 129.1, 129.5, 
129.8, 130.0, 141.6 (aryl). 
(dme)TaCl3(NN(p-Br-Ph)2). Yielded 1.10 g (54.8%). 1H NMR (500 MHz, CD2Cl2) δ, 
ppm: 3.97 (s, 3H, CH3O), 4.04 (s, 3H, CH3O), 4.14 (m, 2H, OCH2), 4.17 (m, 2H, OCH2), 
7.36 (m, 4H, aryl), 7.51 (m, 4H, aryl). 13C NMR (125 MHz, CD2Cl2) δ, ppm: 63.8 (OCH2), 
70.9 (OCH2), 72.3 (OCH3), 76.4 (OCH3), 117.7, 121.8, 122.0, 122.5, 122.7, 131.9, 132.1, 
132.4, 132.7, 142.0 (aryl). Calcd for C16H18Br2Cl3N2O2Ta: C 26.79, H 2.53, N 3.90; Found 
C 27.32, H 2.55, N 3.79%. 
(dme)TaCl3(NNPh2). Yielded 1.32 g (84.3%). Spectral data same as previously 
reported in reference 10. 
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(dme)NbCl3(Ncarbazole). Yielded 410 mg (23.6%). 1H NMR (500 MHz, CD2Cl2) δ, 
ppm: 4.00 (s, 3H, CH3O), 4.10 (s, 3H, CH3O), 4.23 (s, 4H, OCH2), 7.31 (t, 2H, aryl), 7.56 
(t, 2H, aryl), 7.99 (d, 2H, aryl), 8.36 (d, 2H, aryl). 13C NMR (125 MHz, CD2Cl2) δ, ppm: 
63.2 (OCH2), 69.4 (OCH2), 71.9 (OCH3), 75.7 (OCH3), 111.8, 112.0, 120.0, 122.6, 127.0, 
139.1 (aryl). Calcd for C16H18Cl3N2NbO2: C 40.92, H 3.86, N 5.97; Found: C 40.81, H 
3.83, N 6.05%. 
(dme)NbCl3(NN(p-Cl-Ph)2). Yielded 850 mg (42.5%). 1H NMR (500 MHz, CD2Cl2) δ, 
ppm: 3.83 (s, 3H, CH3O), 3.96 (s, 3H, CH3O), 4.10 (s, 4H, OCH2), 7.40 (m, 4H, aryl), 7.47 
(m, 4H, aryl). 13C NMR (125 MHz, CD2Cl2) δ, ppm: 62.8 (OCH2), 69.2 (OCH2), 71.6 (OCH3), 
75.6 (OCH3), 121.1, 121.5, 122.0, 128.9, 129.2, 129.8, 130.8, 140.0 (aryl). Calcd for 
C16H18Cl5N2NbO2: C 35.55, H 3.36, N 5.18; Found C 35.81, H 3.59, N 5.14%. 
(dme)NbCl3(NN(p-Br-Ph)2). Yielded 525 mg (22.5%). 1H NMR (500 MHz, CD2Cl2) δ, 
ppm: 3.83 (s, 3H, CH3O), 3.96 (s, 3H, CH3O), 4.11 (s, 4H, OCH2), 7.41 (m, 4H, aryl), 7.55 
(m, 4H, aryl). 13C NMR (125 MHz, CD2Cl2) δ, ppm: 62.8 (OCH2), 69.2 (OCH2), 71.6 (OCH3), 
75.5 (OCH3), 118.5, 121.5, 121.8, 122.3, 131.9, 132.4, 140.4 (aryl). Calcd for 
C16H18Br2Cl3N2NbO2: C 30.53, H 2.88, N 4.45; Found C 31.76, H 2.88, N 4.54%. 
(dme)NbCl3(NNPh2). Yielded 1 g (57.3%). Spectral data same as previously 
reported in reference 10. 
 (dme)NbCl3(NN(p-CH3-Ph)2). Yielded 100 mg (5.4%). 1H NMR (500 MHz, CD2Cl2) δ, 
ppm: 2.39 (s, 6H, C6H4CH3), 3.85 (s, 3H, CH3O), 3.93 (s, 3H, CH3O), 4.08 (s, 4H, OCH2), 
7.22 (m, 4H, aryl), 7.35 (m, 4H, aryl). 13C NMR (125 MHz, CD2Cl2) δ, ppm: 20.6 (CH3), 
62.6 (OCH2), 69.1 (OCH2), 71.5 (OCH3), 75.4 (OCH3), 120.0, 129.3, 135.3, 139.2 (aryl). 
Calcd for C18H24Cl3N2NbO2: C 43.27, H 4.84, N 5.61; Found C 43.59, H 4.76, N 5.68%. 
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(dme)NbCl3(NN(p-CH3O-Ph)2). Yielded 120 mg (6.1%). 1H NMR (500 MHz, CD2Cl2) 
δ, ppm: 3.81 (s, 6H, C6H4OCH3), 3.85 (s, 3H, CH3O), 3.92 (s, 3H, CH3O), 4.08 (m, 4H, 
OCH2), 6.95 (m, 4H, aryl), 7.37 (m, 4H, aryl). 
(dme)NbCl3(NNPhMe). Yielded 111 mg (7.3%). 1H NMR (500 MHz, CD2Cl2) δ, ppm: 
3.88 (s, 3H, NCH3), 3.95 (s, 3H, CH3O), 4.03 (s, 3H, CH3O), 4.11 (m, 2H, OCH2), 4.17 (m, 
2H, OCH2), 6.92 (t, 1H, aryl), 7.30 (d, 2H, aryl), 7.37 (t, 2H, aryl). 13C NMR (125 MHz, 
CD2Cl2) δ, ppm: 62.5 (OCH2), 69.2 (OCH2), 71.5 (OCH3), 75.5 (OCH3), 112.4, 122.7, 
128.4, 143.8 (aryl). Calcd for C11H18Cl3N2NbO2: C 32.26, H 4.43, N 6.84; Found C 32.07, 
H 4.36, N 6.72%. 
(dme)NbCl3(NNMe2). Yielded 732 mg (56.9%). 1H NMR (500 MHz, CD2Cl2) δ, ppm: 
3.14 (s, 6H, N(CH3)2), 3.86 (s, 3H, CH3O), 4.03 (m, 2H, OCH2), 4.10 (m, 2H, OCH2), 4.10 
(s, 3H, CH3O). 13C NMR (125 MHz, CD2Cl2) δ, ppm: 43.6 (N(CH3)2), 62.1 (OCH2), 69.1 
(OCH2), 71.3 (OCH3), 75.4 (OCH3). 
(dme)NbCl3(Npiperidyl). Yielded 150 mg (10.5%). 1H NMR (500 MHz, CD2Cl2) δ, 
ppm: 1.47 (m, 2H, N(CH2)4CH2) 1.66 (m, 4H, N(CH2)2(CH2)2CH2), 3.14 (s, 6H, N(CH3)2), 
3.49 (m, 4H, N(CH2)2(CH2)3), 3.86 (s, 3H, CH3O), 4.02 (m, 2H, OCH2), 4.09 (m, 2H, OCH2), 
4.09 (s, 3H, CH3O). 13C NMR (125 MHz, CD2Cl2) δ, ppm: 23.8 (CH2); 25.3 (CH2); 54.6 
(CH2); 62.5 (OCH2), 69.2 (OCH2), 71.6 (OCH3), 75.7 (OCH3). Calcd for C9H20Cl3N2NbO2: C 
27.89, H 5.20, N 7.23; Found C 27.79, H 4.99, N 7.22%. 
General Synthesis of (MeCN)WCl4(NNR2). A modified literature procedure was 
used. WCl6 (1 g, 2.52 mmol, 1 equiv) was slurried in 15 mL CH2Cl2 in an inert 
atmosphere glovebox. The appropriate 1,1-disubstituted hydrazine (2.52 mmol, 1 
equiv) dissolved in 2 mL CH2Cl2 was added dropwise to the slurried WCl6 over the course 
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of 10 minutes. The reaction was left to stir for 1 hour, then 1 mL MeCN was added. The 
reaction was stirred for 1 hour and then filtered. The dark filtrate was then added to 150 
mL of vigorously stirred pentane, which resulted in the precipitation of the desired 
product as an orange or purple microcrystalline material. The product was collected via 
filtration and washed with 20 mL pentane. 
(CH3CN)WCl4(Ncarbazole). Yielded (%). 1H NMR (500 MHz, CD2Cl2) δ, ppm: 2.63 (s, 
3H, CH3CN), 7.07 (t, 2H, aryl), 7.68 (t, 2H, aryl), 7.92 (d, 2H, aryl), 8.10 (d, 2H, aryl). 
13C NMR (125 MHz, CD2Cl2) δ, ppm: 4.4 (CH3CN), 121.6 (CH3CN), 115.8, 119.8, 123.8, 
126.5, 129.0, 134.2 (aryl). Calcd for C14H11Cl4N3W: C 30.75, H 2.03, N 7.68; Found C 
28.98, H 2.29, N 7.27%. 
(CH3CN)WCl4(NN(p-Cl-Ph)2). Yielded 1.15 g (73.9%). 1H NMR (500 MHz, CD2Cl2) δ, 
ppm: 2.56 (s, 3H, CH3CN), 7.21 (m, 4H, aryl), 7.67 (m, 4H, aryl). 13C NMR (125 MHz, 
CD2Cl2) δ, ppm: 4.4 (CH3CN), 121.3 (CH3CN), 126.2, 126.7, 128.8, 129.0, 129.1, 129.4, 
129.5, 131.5, 136.9 (aryl.) 
(CH3CN)WCl4(NN(p-Br-Ph)2). Yielded 1.40 g (79.2%). 1H NMR (500 MHz, CD2Cl2) δ, 
ppm: 2.55 (s, 3H, CH3CN), 7.15 (m, 4H, aryl), 7.82 (m, 4H, aryl). 13C NMR (125 MHz, 
CD2Cl2) δ, ppm: 4.4 (CH3CN), 120.9 (CH3CN), 124.5, 125.6, 126.0, 126.5, 131.5, 131.7, 
131.8, 131.9, 132.1 (aryl.) 
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X-Ray Crystallography Data 
 
Table S1. Bond distances and sum of angles about Nβ in (dme)MCl3(NNR2) and 
(MeCN)WCl4(NNR2). 
M R2 M-N (Å) N-N (Å) Σ (°Nβ) 
Ta C12H8 (1a) 1.7605(1) 1.3609(1) 359.0 
 (p-BrPh)2 (1c) 1.760 1.3608 358.7 
 Ph2 (1d)a 1.773(1) 1.347(1) 359.7 
 (p-CH3Ph)2 (1e) 1.7739(3) 1.3400(2) 358.8 
Nb C12H8 (2a) 1.7742(1) 1.3282(1) 359.9 
 (p-ClPh)2 (2b) 1.7661(1) 1.3335(1) 359.1 
 (p-BrPh)2 (2c) 1.7719(1) 1.3374(1) 360.0 
 Ph2 (2d)a 1.7654(1) 1.3447(1) 359.9 
 (p-CH3Ph)2 (2e) 1.7684(1) 1.3305(1) 359.6 
 (p-CH3OPh)2 (2f) 1.7701(1) 1.3362(1) 359.5 
 (CH3)(Ph) (2g) 1.7726(1) 1.3242(1) 360.0 
 (CH3)2 (2h) 1.7601(1) 1.3508(1) 342.1 
 C5H10 (2i) 1.7597(1) 1.3392(1) 341.1 
W Ph2 (3d)b 1.742(4) 1.312(5) 359.3 
 (CH3)2 (3h)b 1.769(5) 1.271(8) 360.0 
 C5H10 (3i) 1.7633(1) 1.2556(1) 359.8 
aTaken from ref. 10. bTaken from ref. 12. cTaken from ref. 16. 
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Table S2. Crystal and refinement data for complexes 1a, 1c, and 1e. 
 1a 1c 1e 









Formula weight 635.73 717.43 587.69 
T (K) 100(2) 100(2) 100(2) 
a, Å 10.9765(4) 7.2890(3) 7.3415(4) 
b, Å 14.9892(6) 13.3859(5) 9.2663(5) 
c, Å 15.2682(6) 10.9809(4) 9.2663(5) 
, deg    78.390(3) 
, deg  110.395(2) 90.292(1) 84.353(3) 
, deg    84.864(2) 
Volume, Å3 2354.58(16) 1071.39(7) 1075.72(10) 
Z 4 2 2 
Crystal system Monoclinic Monoclinic Triclinic 
Space group P21/c P21 P-1 
dcalc, g/cm3 1.793 2.218 1.814 
 range, deg  1.97 to 43.56 1.85 to 30.53 2.25 to 51.69 
, mm-1 5.030 11.000 5.496 
Abs. Correction Semi-Empirical Semi-Empirical Semi-Empirical 
GOF 1.892 1.455 1.218 
R1 ,a  
wR2 b [I>2 (I)]  
R1 = 0.0253,  
wR2 = 0.0359 
R1 = 0.0196, 
wR2 = 0.0380 
R1 = 0.0237,  
wR2 = 0.0343 
a R1 = ∑||Fo| - |Fc||/∑|Fo|.  b wR2 = [∑[w(Fo2-Fc2)2]/∑[w(Fo2)2]1/2. 
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Table S3. Crystal and refinement data for complexes 2a, 2b, and 2c. 
 2a 2b 2c 
CCDC Number 85445 855001 856445 
Empirical formula C16H18Cl3N2NbO2 C16H18N2O2Cl5Nb C16H18Br2Cl3N2NbO2 
Formula weight 469.58 540.48 629.40 
T (K) 100(2) 100(2) 100(2) 
a, Å 19.4748(9) 7.3791(4) 8.8532(4) 
b, Å 9.6654(4) 8.9250(4) 26.6360(13) 
c, Å 19.3262(9) 16.3801(8) 9.4480(5) 
, deg   80.331(2)  
, deg  93.727(2) 84.651(2) 99.838(2) 
, deg   85.152(2)  
Volume, Å3 3630.1(3) 1056.20(9) 2195.21(19) 
Z 8 2 4 
Crystal system Monoclinic Triclinic Monoclinic 
Space group C 2/c P-1 P21/n 
dcalc, g/cm3 1.718 1.699 1.904 
 range, deg  2.10 to 55.67 2.32 to 40.82 2.32 to 45.45 
, mm-1 1.116 1.216 4.567 
Abs. Correction None None None 
GOF 2.165 2.169 1.445 
R1 ,a  
wR2 b [I>2 (I)]  
R1 = 0.0263,  
wR2 = 0.0445 
R1 = 0.0203,  
wR2 = 0.0515 
R1 = 0.0247, 
wR2 = 0.0401 
a R1 = ∑||Fo| - |Fc||/∑|Fo|.  b wR2 = [∑[w(Fo2-Fc2)2]/∑[w(Fo2)2]1/2. 
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Table S4. Crystal and refinement data for complexes 2e, 2f, and 2g. 
 2e 2f 2g 









Formula weight 499.65 577.72 409.53 
T (K) 100(2) 100(2) 100(2) 
a, Å 7.3620(4) 7.4401(3) 7.6003(4) 
b, Å 9.2470(5) 10.5793(5) 10.5217(6) 
c, Å 16.2248(10) 16.3555(7) 11.2752(6) 
, deg  78.177(3) 97.7650(10)° 64.736(2) 
, deg  85.220(3) 95.120(2)° 79.530(2) 
, deg  84.498(3) 99.874(2)° 83.340(2) 
Volume, Å3 1073.81(11) 1248.30(9) 801.09(8) 
Z 2 2 2 
Crystal system Triclinic Triclinic Triclinic 
Space group P-1 P-1 P-1 
dcalc, g/cm3 1.545 1.537 1.698 
 range, deg  2.26 to 44.88 1.26 to 30.57 2.02 to 51.72 
, mm-1 0.948 0.830 1.250 
Abs. Correction None Semi Empirical None 
GOF 2.163 2.445 2.009 
R1 ,a  
wR2 b [I>2 (I)]  
R1 = 0.0237,  
wR2 = 0.0556 
R1 = 0.0332, 
wR2 = 0.0624 
R1 = 0.0223,  
wR2 = 0.0476 
a R1 = ∑||Fo| - |Fc||/∑|Fo|.  b wR2 = [∑[w(Fo2-Fc2)2]/∑[w(Fo2)2]1/2. 
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Table S5. Crystal and refinement data for complexes 2h, 2i, and 3i. 
 2h 2i 3i 
CCDC Number 855020 855260 855852 
Empirical formula C6H16N2O2Cl3Nb C9H20N2O2Cl3Nb C7H13N3Cl4W 
Formula weight 347.47 387.53 464.85 
T (K) 100(2) 100(2) 100(2) 
a, Å 20.6913(14) 6.8865(3) 9.6582(4) 
b, Å 12.5611(8) 12.1853(5) 14.7762(7) 
c, Å 15.4117(10) 18.5285(8) 9.7818(4) 
, deg     
, deg  90.294(4)  92.958(2) 
, deg     
Volume, Å3 4005.5(5) 1554.80(11) 1394.12(10) 
Z 12 4 4 
Crystal system Monoclinic Orthorhombic Monoclinic 
Space group P21/c P212121 P21/n 
dcalc, g/cm3 1.729 1.656 2.215 
 range, deg  1.90 to 44.67 2.00 to 47.65 2.50 to 53.16 
, mm-1 1.482 1.282 9.026 
Abs. Correction None None Semi Empirical 
GOF 1.516 1.310 1.462 
R1 ,a  
wR2 b [I>2 (I)]  
R1 = 0.0287,  
wR2 = 0.0408 
R1 = 0.0313,  
wR2 = 0.0417 
R1 = 0.0210,  
wR2 = 0.0323 
a R1 = ∑||Fo| - |Fc||/∑|Fo|.  b wR2 = [∑[w(Fo2-Fc2)2]/∑[w(Fo2)2]1/2. 
 
